For: | Tan W, Lim SG, Tan TM. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1. World J Gastroenterol 2015; 21(46): 13030-13041 [PMID: 26676187 DOI: 10.3748/wjg.v21.i46.13030] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i46/13030.htm |
Number | Citing Articles |
1 |
Guochen Zhang, Junlan Wang, Ruilin Zheng, Beibei Song, Li Huang, Yujiang Liu, Yating Hao, Xiangdong Bai. MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820927011
|
2 |
Xiaona Zhang, Xu Gong, Jinpeng Qiu, Yang Zhang, Fengyan Gong. MicroRNA-210 contributes to peripheral nerve regeneration through promoting the proliferation and migration of Schwann cells. Experimental and Therapeutic Medicine 2017; 14(4): 2809 doi: 10.3892/etm.2017.4869
|
3 |
Hamdy E. Abouzeid Ali, Rehab Abdel Hameed, Heba Effat, Emad K. Ahmed, Azza A. Atef, Sabry K. Sharawi, Mohamed Ali, Zakaria Y. Abd Elmageed, Abdel Hady Abdel Wahab. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2017; 41(4): e51 doi: 10.1016/j.clinre.2017.06.004
|
4 |
Zheng Fang, Shuai Yin, Ruochuan Sun, Shangxin Zhang, Min Fu, Youliang Wu, Tao Zhang, Junaid Khaliq, Yongxiang Li. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0708-6
|
5 |
Baoyong Wang, Hongwei Chen, Chunfen Zhang, Tian Yang, Qiaofei Zhao, Yifan Yan, Yu Zhang, Feng Xu. Effects ofhsa_circRBM23on Hepatocellular Carcinoma Cell Viability and Migration as Produced by Regulating miR-138 Expression. Cancer Biotherapy and Radiopharmaceuticals 2018; 33(5): 194 doi: 10.1089/cbr.2017.2424
|
6 |
Shouyue Liu, Tao Jiang, Yingjie Zhong, Yin Yu. miR‐210 inhibits cell migration and invasion by targeting the brain‐derived neurotrophic factor in glioblastoma. Journal of Cellular Biochemistry 2019; 120(7): 11375 doi: 10.1002/jcb.28414
|
7 |
Wenbing Sun, Shuqi Fu, Size Wu, Rong Tu, Diego Franco. Growing Evidence of Exosomal MicroRNA‐Related Metastasis of Hepatocellular Carcinoma. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/4501454
|
8 |
Lóránd Váncza, Katalin Karászi, Bálint Péterfia, Lilla Turiák, Katalin Dezső, Anna Sebestyén, Andrea Reszegi, Gábor Petővári, András Kiss, Zsuzsanna Schaff, Kornélia Baghy, Ilona Kovalszky. SPOCK1 Promotes the Development of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.819883
|
9 |
Philipp Felgendreff, Nathanael Raschzok, Kerstin Kunze, Annekatrin Leder, Steffen Lippert, Sergej Klunk, Hans-Michael Tautenhahn, Hans-Michael Hau, Rosa Bianca Schmuck, Anja Reutzel-Selke, Igor Maximilian Sauer, Michael Bartels, Mehmet Haluk Morgül. Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma. Biomarkers 2020; 25(1): 62 doi: 10.1080/1354750X.2019.1691267
|
10 |
Germana Zaccagnini, Simona Greco, Christine Voellenkle, Carlo Gaetano, Fabio Martelli. miR-210 hypoxamiR in Angiogenesis and Diabetes. Antioxidants & Redox Signaling 2022; 36(10-12): 685 doi: 10.1089/ars.2021.0200
|
11 |
László Bányai, Maria Trexler, Krisztina Kerekes, Orsolya Csuka, László Patthy. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. eLife 2021; 10 doi: 10.7554/eLife.59629
|
12 |
Wei Guo, Dong-Mei Shang, Jing-Hui Cao, Kaiyan Feng, Yi-Chun He, Yang Jiang, ShaoPeng Wang, Yu-Fei Gao. Identifying and Analyzing Novel Epilepsy-Related Genes Using Random Walk with Restart Algorithm. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/6132436
|
13 |
Yuqiang Xu, Kuikui Ge, Junhao Lu, Jinjiang Huang, Wei Wei, Qingshan Huang. MicroRNA-493 suppresses hepatocellular carcinoma tumorigenesis through down-regulation of anthrax toxin receptor 1 (ANTXR1) and R-Spondin 2 (RSPO2). Biomedicine & Pharmacotherapy 2017; 93: 334 doi: 10.1016/j.biopha.2017.06.047
|
14 |
Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Daiming Fan, Liu Hong. Biological implications and clinical value of mir-210 in gastrointestinal cancer. Expert Review of Gastroenterology & Hepatology 2017; 11(6): 539 doi: 10.1080/17474124.2017.1309281
|
15 |
Runglawan Silakit, Yingpinyapat Kitirat, Suyanee Thongchot, Watcharin Loilome, Anchalee Techasen, Piti Ungarreevittaya, Narong Khuntikeo, Puangrat Yongvanit, Ji Hye Yang, Nam Hee Kim, Jong In Yook, Nisana Namwat, Fabio Martelli. Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. PLOS ONE 2018; 13(6): e0199827 doi: 10.1371/journal.pone.0199827
|
16 |
Risks With Use of Oral Propranolol for Infantile Hemangioma. AAP Grand Rounds 2018; 40(3): 33 doi: 10.1542/gr.40-3-33
|
17 |
Jingcheng Wang, Yang Tian, Hui Chen, Hui Li, Shusen Zheng. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8871
|
18 |
Xudong Ren, Yu Zhou, Yunling Luo, Chaoqun Wang, Anna Pan, Yanqin Ju, Haoting Sun, Zhifei Lin, Beiyuan Hu, Guangzheng Sun, Wenwei Zhu, Liang Hong, Zhihua Kang. IL-6 Promotes Hepatocellular Carcinoma Invasion by Releasing Exosomal miR-133a-3p. Gastroenterology Research and Practice 2022; 2022: 1 doi: 10.1155/2022/4589163
|